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From the Midwestern Vascular Surgical Society

Physical therapy management, surgical treatment, and
patient-reported outcomes measures in a prospective
observational cohort of patients with neurogenic
thoracic outlet syndrome
Joshua Balderman, MD,a,b Ahmmad A. Abuirqeba, BA,a,b Lindsay Eichaker, DPT,c
Cassandra Pate, MSPT, LMT,c Jeanne A. Earley, MHS, PT,c Michael M. Bottros, MD,a,d
Senthil N. Jayarajan, MD, MS,a,b and Robert W. Thompson, MD,a,b St. Louis, Mo

ABSTRACT
Objective: To assess the results of physical therapy management and surgical treatment in a prospective observational
cohort of patients with neurogenic thoracic outlet syndrome (NTOS) using patient-reported outcomes measures.
Methods: Of 183 new patient referrals from July 1 to December 31, 2015, 150 (82%) met the established clinical diagnostic
criteria for NTOS. All patients underwent an initial 6-week physical therapy trial. Those with symptom improvement
continued physical therapy, and the remainder underwent surgery (supraclavicular decompression with or without
pectoralis minor tenotomy). Pretreatment factors and 7 patient-reported outcomes measures were compared between
the physical therapy and surgery groups using t-tests and c2 analyses. Follow-up results were assessed by changes in
11-item version of Disability of the Arm, Shoulder, and Hand (QuickDASH) scores and patient-rated outcomes.
Results: Of the 150 patients, 20 (13%) declined further treatment or follow-up, 40 (27%) obtained satisfactory improvement with physical therapy alone, and 90 (60%) underwent surgery. Slight differences were found between the physical
therapy and surgery groups in the mean 6 standard error degree of local tenderness to palpation (1.7 6 0.1 vs 2.0 6 0.1;
P ¼ .032), the number of positive clinical diagnostic criteria (9.0 6 0.3 vs 10.1 6 0.1; P ¼ .001), Cervical-Brachial Symptom
Questionnaire scores (68.0 6 4.1 vs 78.0 6 2.7; P ¼ .045), and Short-Form 12-item physical quality-of-life scores (35.6 6 1.5 vs
32.0 6 0.8; P ¼ .019) but not other pretreatment factors. During follow-up (median, 21.1 months for physical therapy and
12.0 months for surgery), the mean change in QuickDASH scores for physical therapy was 15.6 6 3.0 (29.5% 6 5.7%)
compared with 29.8 6 2.4 (47.9% 6 3.6%) for surgery (P ¼ .001). The patient-rated outcomes for surgery were excellent
for 27%, good for 36%, fair for 26%, and poor for 11%, with a strong correlation between the percentage of decline in the
QuickDASH score and patient-rated outcomes (P < .0001).
Conclusions: The present study has demonstrated contemporary outcomes for physical therapy and surgery in a wellstudied cohort of patients with NTOS, reinforcing that surgery can be effective when physical therapy is insufﬁcient,
even with substantial pretreatment disability. Substantial symptom improvement can be expected for w90% of patients
after surgery for NTOS, with treatment outcomes accurately reﬂected by changes in QuickDASH scores. Within this
cohort, it was difﬁcult to identify speciﬁc predictive factors for individuals most likely to beneﬁt from physical therapy
alone vs surgery. (J Vasc Surg 2019;70:832-41.)
Keywords: Brachial plexus; Chronic pain; Compression neuropathy; Depression; Disability; Patient-reported outcomes
measures; Pain catastrophizing; Physical therapy; Quality of life; Surgical treatment; Thoracic outlet syndrome

Neurogenic thoracic outlet syndrome (NTOS) is a relatively rare, complicated, and, at times, controversial
condition characterized by dynamic positional
compression of the brachial plexus at the level of the

supraclavicular scalene triangle or the subcoracoid
(pectoralis minor) space.1-3 Some of the longstanding,
but unresolved, questions about NTOS have involved
the most appropriate criteria for the diagnosis, accurate
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Fig 1. Schematic ﬂow diagram for a prospective observational cohort of patients with neurogenic thoracic outlet
syndrome (NTOS). Dx, Diagnostic.

assessment and reporting of treatment results, and
approaches to better predict individual patient outcomes for various treatment options.1-5 During the
past decade, the Consortium for Research and Education on Thoracic Outlet Syndrome (CORE-TOS) sought
to address the question of diagnostic standards, using
a Delphi approach to develop a set of consensusbased clinical diagnostic criteria (CDC) for NTOS.6,7
Our group, and others, has also attempted to establish
more accurate methods to quantify the disability and
assess the treatment results in patients with NTOS
using patient-reported outcomes measures (PROMs)
for different, but related, domains, such as pain, functional disability, depression, physical and mental quality
of life (QOL), and pain catastrophizing.7-19
In a recent report, we described a prospective observational cohort study in which the relative strengths of the
14 CORE-TOS CDC and 7 PROMs were examined in
patients with suspected NTOS.7 The results helped validate the utility of the CDC used for evaluation of NTOS
and demonstrated strong correlations between PROMs
covering different domains of symptomatic disability.
The purpose of the present study was to extend our analysis of this prospective cohort to compare the results of
physical therapy management and surgical treatment
during follow-up using both PROMs and patient-rated
outcomes and to evaluate the potential associations
between the clinical features at initial presentation and
treatment outcomes.

Type of Research: Retrospective cohort study of prospectively collected data
Key Findings: During a median follow-up
>12 months of 130 patients with neurogenic thoracic
outlet syndrome, 40 (31%) obtained symptom
improvement with physical therapy alone and 90
(69%) underwent surgery, with a percentage of
decline in Disability of the Arm, Shoulder, and
Hand scores of 29.5% 6 5.7% and 47.9% 6 3.6%,
respectively.
Take Home Message: Despite substantial pretreatment disability, surgery for neurogenic thoracic
outlet syndrome can be effective when physical therapy is insufﬁcient, with substantial symptom
improvement in w90% of patients. These outcomes
were reﬂected by changes in Disability of the Arm,
Shoulder, and Hand scores, but no speciﬁc factors
predicted which patients will beneﬁt from physical
therapy alone or will require surgery.

METHODS
Study population and clinical diagnosis. All the subjects in the present study gave written informed consent
for the report of their medical data through a protocol
approved by the human research protection ofﬁce at
Washington University (St. Louis, Mo). The initial study
population consisted of all new patients referred to the
Washington University Center for Thoracic Outlet Syndrome at Barnes Jewish Hospital from July 1 to
December 31, 2015. Data collected from ofﬁce notes, hospital records, imaging studies, and records from the
treating physicians and therapists were entered into a
prospectively maintained database. Of the 183 newly
referred patients, 150 (82%) had met the predeﬁned
CORE-TOS CDC for NTOS, as reported previously.7 Each
patient had also met the diagnostic criteria for NTOS
described in the 2016 reporting standards of the Society
for Vascular Surgery.2 The results from the imaging
studies and electrophysiological tests were not considered necessary to establish a clinical diagnosis of NTOS
but were used for selected patients to help assess or
exclude other conditions. Ultrasound-guided local
anesthetic anterior scalene and pectoralis minor muscle
blocks were also used selectively to identify variations
in anatomy and, potentially, provide prognostic information.20-22 The 150 patients with a veriﬁed diagnosis of
NTOS represented the starting patient population for the
present study (Fig 1).
Treatment algorithm. All patients with NTOS underwent a physical therapy evaluation and treatment guided
by 1 of 3 physical therapists aligned with our TOS Center at
The Rehabilitation Institute of St. Louis. The physical
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Table I. Patient characteristics at presentation
Physical therapy alone (n ¼ 40)

Surgical treatment (n ¼ 90)

P value

37.7 6 2.3

36.9 6 1.4

.759a

29 (72)

66 (73)

1.000b

11 (27)

21 (23)

.661b

1 (2)

9 (9)

.174b

3-6 months

6 (15)

11 (12)

.779b

6-12 months

8 (20)

14 (16)

.614b

1-2 years

5 (12)

12 (13)

1.00b

2-5 years

13 (32)

21 (24)

>5 years

8 (20)

32 (35)

>2 years

21 (52)

53 (59)

.566b

None

11 (27)

16 (18)

.244b

Accidental

7 (17)

18 (20)

.814b

Recreational

13 (32)

24 (27)

.531b

Occupational

9 (22)

32 (35)

.157b

All types

29 (72)

74 (82)

.244b

1.7 6 0.1

2.0 6 0.1

.032a

Characteristic
Age, years
Female gender
NTOS
Bilateral
Recurrent
Symptom duration

.287b
1.00b

Previous injury

Degree of tendernessc
Subcoracoid ﬁndings only

2 (5)

4 (4)

1.00b

103.0 6 10.2

97.0 6 6.3

.610a

9.0 6 0.3

10.1 6 0.1

.001a

52.9 6 3.4

60.3 6 2.1

.058a

CBSQ

68.0 6 4.1

78.0 6 2.7

.045a

McGill pain score

29.4 6 2.1

29.6 6 1.1

.928a

3-Minute EAST, seconds
c

Positive CDC, n
QuickDASH score
c

BPI
Severity

4.9 6 0.3

5.0 6 0.2

.785a

Interference

5.2 6 0.4

5.4 6 0.2

.616a

42.5 6 1.6

43.0 6 1.0

.774a

SF-12 physical QOL

35.6 6 1.5

32.0 6 0.8

.019a

SF-12 mental QOL

46.1 6 1.8

47.8 6 1.1

.423a

24.9 6 2.3

24.5 6 1.5

.864a

Zung SDS score
c

PCS score
Overall
Rumination

9.1 6 0.8

8.7 6 0.5

.679a

Magniﬁcation

3.9 6 0.6

4.4 6 0.3

.459a

11.4 6 0.7

.651a

Helplessness

12.0 6 1.2

BPI, Brief Pain Inventory; CBSQ, Cervical-Brachial Symptom Questionnaire; CDC, clinical diagnostic criteria; EAST, elevated arm stress test; NTOS,
neurogenic thoracic outlet syndrome; PCS, Pain Catastrophizing Scale; QOL, quality of life; QuickDASH, 11-item version of the Disabilities of the Arm,
Shoulder, and Hand; SDS, Self-rating Depression Scale; SF-12, Short-Form, 12-item questionnaire.
Data are presented as mean 6 standard error for continuous measures and number of patients (%) for categorical variables. Of the 150 patients, 20
(13%) declined further treatment or follow-up, leaving 130 for assessment of physical therapy management alone (n ¼ 40) or surgical treatment
(n ¼ 90).
a
Unpaired t-test.
b
Fisher’s exact test.
c
P < .05.

therapy program consisted of scalene and pectoralis muscle stretching and relaxing exercises, with a focus on
shoulder girdle and scapular mobility, mechanics,
postural improvement, and diaphragmatic breathing, using caution with strengthening, weight training, and the
use of resistance bands.23-27 For patients residing at a

distance from St. Louis, the physical therapy trial was
implemented by a therapist located closer to the patient,
with guidance, oversight, and follow-up assessment provided by the TOS Center therapist. Physical therapy was
conducted for 4 to 6 weeks, unless the patient had previously undergone physical therapy considered appropriate
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previously described.13 Postoperative complications,
hospital stay, and readmissions were all recorded in the
prospective database. The surgery patients resumed
physical therapy 3 to 4 weeks postoperatively, preferably
with the same TOS Center therapist with whom they had
worked during the initial physical therapy trial.

Fig 2. Treatment outcomes after physical therapy or surgery for neurogenic thoracic outlet syndrome (NTOS). A,
Bar graphs depicting Disability of the Arm, Shoulder, and
Hand (QuickDASH) scores before and during follow-up
after physical therapy and surgical treatment. Two-group
comparisons were performed using the unpaired t-test.
B, Bar graph depicting the response to treatment
measured by the percentage of improvement in QuickDASH scores and patient-rated outcomes for surgical
treatment. Multiple-group comparison was performed
using the Kruskal-Wallis analysis of variance. SEM, Standard error of the mean.

by the TOS Center therapist or if their symptoms had
worsened during the initial therapy visits, in which case,
earlier consideration was given for surgical treatment.
During the ofﬁce follow-up visit and reassessment,
patients who experienced an improvement in symptoms
during the initial course of physical therapy were encouraged to continue with physical therapy. Surgery was
offered to patients who had a sound clinical diagnosis
of NTOS, a signiﬁcant level of disability, and insufﬁcient
improvement in symptoms with physical therapy, as
determined by the assessment of the physician, therapist, and patient.
Surgical treatment. Throughout the study period, surgery for NTOS consisted of supraclavicular decompression (with complete anterior and middle scalenectomy,
ﬁrst rib resection, and brachial plexus neurolysis) or subcoracoid decompression (pectoralis minor tenotomy),
or both, as previously described in detail.28-30 The site of
operative decompression was determined for each
patient from the clinical examination ﬁndings at the level
of the scalene triangle or subcoracoid space, as

Follow-up and patient-reported outcomes measures.
The patients were seen for ofﬁce visits every 3 to 4 months
after the start of treatment, and more frequently when
necessary. At each visit, the patients were asked to complete the Disabilities of the Arm, Shoulder and Hand
(QuickDASH) survey instrument, Cervical-Brachial
Symptom Questionnaire (CBSQ), McGill pain questionnaire (McGill), Brief Pain Inventory, Zung self-rating
depression scale, Short-Form, 12-item physical and
mental summary scales (SF-12), and pain catastrophizing
scale (PCS), as previously described.7 The patients who
had undergone surgery were also asked to rate their
treatment outcome using a simple scale with the
descriptors “excellent” (relief of almost all major symptoms with only some mild residual symptoms that do
not signiﬁcantly limit enjoyment of life), “good” (relief of
most major symptoms with some mild residual symptoms that signiﬁcantly limit enjoyment of life), “fair”
(partial relief of some symptoms while other major
symptoms persist), or “poor” (not enough relief in symptoms to have made the operation worthwhile).
Statistical analysis. The principal outcomes measure
was the percentage of improvement in the QuickDASH
score between the initial evaluation and the longest
follow-up interval. Descriptive data are presented as the
mean 6 standard error or the median and range. For the
2-group comparisons, a c2 analysis or the unpaired Student t-test with a 2-tailed distribution were used to
determine statistical signiﬁcance. For multiple-group
comparisons, the Kruskal-Wallis nonparametric analysis
of variance (ANOVA) test was used with the Dunn multiple comparisons test. In selected instances, Spearman
correlation tests were performed with calculation of the
r and R2 values. Receiver operating characteristic curves
were constructed to assess a cutoff point for change in
QuickDASH scores that corresponded to positive patientrated outcomes. The cutoff point was calculated on the
basis of the best trade-off value between sensitivity and
speciﬁcity. Multivariate logistic regression analysis was
performed with calculation of the odds ratios to predict
the optimal change in the QuickDASH scores. All statistical tests were performed using Prism, version 6.0h
(GraphPad Software Inc, San Diego, Calif), with P < .05
considered statistically signiﬁcant.

RESULTS
Outcomes of initial physical therapy trial. Of the initial
cohort of 150 patients meeting the CDC for NTOS, 20
(13%) declined further treatment or follow-up (Fig 1). Of
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Table II. Response to treatment stratiﬁed by surgical procedure
Follow-up assessments

Patients, No.

Initial assessment
(QuickDASH)

QuickDASH

Delta DASH

Change, %

SCD, ipsilateral PMT

70

62.6 6 2.2

27.7 6 2.5

34.5 6 2.8

55.2 6 3.6a

SCD, bilateral PMT

Variable

12

61.7 6 4.3

42.5 6 6.4

20.7 6 4.6

34.2 6 7.5

SCD alone

4

39.5 6 16.0

11.3 6 7.3

17.8 6 10.1

41.8 6 21.0

PMT alone

4

36.9 6 12.2

30.5 6 12.3

6.4 6 6.5

þ4.6 6 35.2a

PMT, Pectoralis minor tenotomy; QuickDASH, 11-item version of the Disabilities of the Arm, Shoulder, and Hand; SCD, supraclavicular decompression.
Data are presented as mean 6 standard error.
a
P ¼ .002, 1-way analysis of variance with Tukey’s multiple comparisons test.

frequency of positive scalene muscle blocks (Table I).
The mean degree of local tenderness to palpation, total
number of positive CDC, and CBSQ scores were lower
for the physical therapy group than for the surgery group,
and the SF-12 physical QOL scores were lower in the surgery group. The pretreatment QuickDASH scores were
not signiﬁcantly different between the 2 groups.

Fig 3. Inﬂuence of patient age on outcomes of surgical
treatment for neurogenic thoracic outlet syndrome
(NTOS). A, Scatter plot illustrating the relationship
between patient age and response to surgical treatment,
measured by the percentage of improvement in Disability
of the Arm, Shoulder, and Hand (QuickDASH) scores. B,
Bar graph depicting QuickDASH scores before and during
follow-up after surgical treatment for patients
aged <40 years and $40 years. Two-group comparisons
were performed using the unpaired t-test.

the remaining 130 patients, 40 (27%) obtained satisfactory symptom improvement with the initial physical
therapy trial and chose to continue conservative management. Finally, 90 patients (60%) experienced insufﬁcient improvement with physical therapy and
subsequently elected to undergo surgery.
No differences were found in the presenting characteristics between the physical therapy and surgery groups
in age, gender, symptom duration, previous injury, painrelated PROM scores, pain catastrophizing scores, or

Surgical treatment. In the surgical treatment group, 20
patients (22.2%) had presented with bilateral NTOS, 4
(4.4%) with a cervical rib, and 7 (7.8%) with recurrent
NTOS after having undergone a previous procedure at
another institution. The mean interval between the initial
ofﬁce visit and surgery was 115 6 11 days. The operations
performed included supraclavicular decompression
and ipsilateral pectoralis minor tenotomy in 70 patients
(77.8%), supraclavicular decompression and bilateral
pectoralis minor tenotomy in 12 (13.3%), supraclavicular
decompression alone in 4 (4.4%), and isolated pectoralis
minor tenotomy in 4 patients (4.4%). No intraoperative
complications developed; however, ﬁve patients (5.5%)
experienced prolonged lymph drainage that required
medical management (low-fat diet and octreotide). The
mean hospital stay was 4.3 6 0.2 days and four patients
(4.4%) required readmission within 30 days (1 each for
subclavian vein thrombosis, thoracic duct embolization,
drainage of a superﬁcial wound infection, and excision
of a stitch granuloma).
Follow-up and treatment outcomes. The mean followup interval was 20.4 6 0.8 months for the physical therapy group and 12.3 6 0.7 months postoperatively for the
surgery group. The mean follow-up QuickDASH score for
the physical therapy group was 37.2 6 3.9 compared with
52.9 6 3.4 at the initial presentation, with a mean decline
in the QuickDASH score of 15.6 6 3.0 (29.5% 6 5.7%;
P < .0001; Fig 2, A). For the surgical treatment group, the
mean follow-up QuickDASH score was 30.4 6 2.3
compared with 60.3 6 2.1 at the initial presentation, with
a mean decline in the QuickDASH score of 29.8 6 2.4
(47.9% 6 3.6%; P < .0001). Although signiﬁcant
improvement was seen in both groups, the percentage
of improvement in the QuickDASH scores was greater for
the surgery group than for the physical therapy group
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Table III. Inﬂuence of muscle block ﬁndings on response to treatment stratiﬁed by treatment received
Follow-up assessment
Variable

Patients, No.

Initial assessment (QuickDASH)

QuickDASH

Delta DASH

Change, %

40

52.9 6 3.4

37.2 6 3.9

15.6 6 3.0

8

59.5 6 8.4

43.3 6 9.7

16.2 6 6.7

27.1 6 11.3

Block performed

32

51.2 6 3.7

35.7 6 4.3

15.5 6 3.4

30.1 6 6.6

Positive ﬁnding

26

53.6 6 4.1

37.4 6 4.9

16.2 6 3.9

30.6 6 7.1a

Negative ﬁnding

6

40.7 6 8.3

28.5 6 8.7

12.2 6 7.2

27.9 6 18.3a

All patients

90

60.3 6 2.1

30.4 6 2.3

29.8 6 2.4

47.9 6 3.6

Physical therapy alone
All patients
No block performed

29.5 6 5.7

Surgical treatment
No block performed

28

55.8 6 4.2

25.8 6 2.9

30.0 6 4.2

46.2 6 7.1

Block performed

62

62.3 6 2.4

32.4 6 3.0

29.7 6 3.0

48.7 6 4.2

Positive ﬁnding

50

62.3 6 2.8

30.3 6 3.3

31.8 6 3.2

52.2 6 4.5b

Negative ﬁnding

12

62.3 6 4.1

41.1 6 7.5

21.2 6 7.6

34.3 6 10.7b

QuickDASH, 11-Item version of the Disabilities of the Arm, Shoulder, and Hand questionnaire.
Data are presented as mean 6 standard error.
a
P ¼ .875, unpaired t-test.
b
P ¼ .092, unpaired t-test.

(P ¼ .001). The results of the outcomes measures were
somewhat different among the patients undergoing
different surgical procedures (P ¼ .002, ANOVA). However, the number of patients in the isolated pectoralis
minor tenotomy and the supraclavicular decompression alone groups was too low (n ¼ 4 each), and the
range of outcomes too broad, to permit reliable
between-group comparisons (Table II). The overall
patient-rated outcomes for surgical treatment were
excellent for 27%, good for 36%, fair for 26%, and poor
for 11% of the surgery group, with a strong relationship
between the percentage of decline in the QuickDASH
score and the patient-rated outcomes category
(P < .0001, ANOVA; Fig 2, B).
Determinants of outcomes after surgical treatment.
Based on the results from previous studies, patient age at
the initial presentation was examined as a potential factor in determining the outcomes of surgery.12,31-33 A signiﬁcant association was found between patient age and
the percentage of improvement in the QuickDASH score
during follow-up (P ¼ .006, Spearman correlation), with
younger patients having better outcomes (Fig 3, A). The
mean follow-up QuickDASH score for patients
aged <40 years (n ¼ 48) was 24.9 6 2.8 compared with
61.0 6 3.0 at the initial presentation, with a mean decline
in the QuickDASH score of 36.2 6 3.5 (55.2% 6 5.4%;
P < .0001; Fig 3, B). The mean follow-up QuickDASH score
for patients age $40 years (n ¼ 42) was 36.7 6 3.5
compared with 59.5 6 2.9 at the initial presentation, with
a mean decline in the QuickDASH score of 22.4 6 3.0
(39.8% 6 4.5%; P < .0001). Although signiﬁcant
improvement was found in both groups, the percentage
of improvement in the QuickDASH scores for patients

aged <40 years was greater than that for patients aged
$40 years (P ¼ .034).
Previous studies have indicated that positive anterior
scalene and pectoralis minor muscle blocks might predict better outcomes from surgical treatment for
NTOS.33-35 In the present cohort, muscle blocks were performed as part of the initial pretreatment evaluation for
32 patients (80%) in the physical therapy group and 62
patients (69%) in the surgical treatment group. For the
patients in the physical therapy group with negative
muscle block ﬁndings, the mean decline in the QuickDASH score was 27.9% 6 18.3% compared with
30.6% 6 7.1% for patients with positive block ﬁndings
(P > .05; Table III). These results demonstrate that positive
muscle block ﬁndings did not effectively predict the
treatment outcomes for the patients undergoing physical therapy management alone. For the patients in the
surgical treatment group with negative muscle block
ﬁndings, the mean decline in the QuickDASH score was
34.3% 6 10.7% compared with 52.2% 6 4.5% for patients
with positive block ﬁndings (P ¼ .092). This ﬁnding indicates signiﬁcant improvement in the surgical group,
regardless of the outcome of the pretreatment muscle
block, with a trend toward a greater percentage of
improvement in the QuickDASH scores for patients
with positive muscle block ﬁndings that did not reach
statistical signiﬁcance.
One of the goals of the present study was to examine
the use of various PROMs measured at the initial patient
presentation to serve as predictors of treatment
outcome, with a particular interest in pain catastrophizing.7 The mean decline in the QuickDASH score was
28.8 6 2.9 (48.2% 6 4.7%) for patients with low pain catastrophizing at the initial presentation (PCS score <30;
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65% of patients; Fig 4, A). The mean decline in QuickDASH score was 31.2 6 4.2 (47.5 6 5.8 percent) for patients
with high pain catastrophizing at initial presentation
(PCS score $30; 35% of patients). Thus, the pretreatment
levels of pain catastrophizing did not have a signiﬁcant
inﬂuence on the surgical treatment outcomes (P > .05).
However, in assessing the potential changes in pain catastrophizing during follow-up, those with favorable
patient-rated outcomes had signiﬁcant decreases in
the mean PCS scores. In contrast, those with poor
patient-rated outcomes exhibited no change (Fig 4, B).
Multivariate analysis. In attempting to better identify
the predictors of clinical outcomes, the patients who
had undergone surgery were divided into “responders”
(patient-rated outcomes of fair, good, or excellent) and
“nonresponders” (patient-rated outcomes of poor). A
threshold cutoff distinguishing the 2 groups was found
at a percentage of improvement in the QuickDASH score
of 27.4%. Multivariate logistic regression analysis was performed with a spectrum of pretreatment variables, controlling for patient age, gender, and symptom duration
>2 years. The pretreatment SF-12 physical QOL score
was the only variable with predictive value in distinguishing positive from negative responses to surgery
(odds ratio, 1.12; P ¼ .031; Fig 5).

DISCUSSION
In the present study, we assessed the results of physical
therapy management and surgical treatment for
patients with NTOS using well-deﬁned CDC for NTOS
and a series of PROMs in a prospective, observational
patient cohort. Our results have demonstrated that
even with substantial levels of pretreatment disability,
physical therapy alone was effective in 31% of the patient
cohort that had continued treatment and follow-up. Surgical treatment was effective when physical therapy
alone was insufﬁcient, with substantial symptom
improvement in w90% of patients. We observed that
surgical treatment outcomes were accurately reﬂected
by changes in the QuickDASH scores measured during
follow-up, reinforcing the validity of this instrument to
quantify the treatment results of patients with NTOS.
We also found no pretreatment factors that allowed for
a sound prediction regarding the individual patients
who might respond sufﬁciently to physical therapy alone
but that an empirical treatment trial was necessary. For
patients undergoing surgery, other than age at presentation, CBSQ score, and SF-12 physical QOL score, we could
not identify any speciﬁc pretreatment factors or patient
proﬁles that reliably predicted the outcomes.
The treatment algorithm followed in the present study
is based on long-established clinical practice and experience in the management of NTOS but differs from the
process described by some investigators. For example,
Chandra et al36 described a “highly selective” algorithm

Fig 4. Association between pretreatment pain catastrophizing and outcomes of surgical treatment for
neurogenic thoracic outlet syndrome (NTOS). A, Bar graph
depicting Disability of the Arm, Shoulder, and Hand
(QuickDASH) scores before and during follow-up after
surgical treatment for patients with low (Pain Catastrophizing Scale [PCS] score <30) and high (PCS score
$30) pain catastrophizing. B, Bar graph depicting changes
in pain catastrophizing after surgical treatment for NTOS
stratiﬁed by patient-rated outcomes for surgical treatment. Two-group comparisons were performed using
the unpaired t-test. *P < .01; **P < .0001. NS, Not signiﬁcant
(P > .05); SEM, standard error of the mean.

with all patients undergoing an initial trial of physical
therapy and surgical treatment reserved for those exhibiting improvement. This approach appears counterintuitive, because some patients with the most disabling
symptoms and the greatest potential for improvement
might not be offered surgical treatment, and at least
some of those with improvement after the initial physical
therapy trial might undergo surgical treatment unnecessarily. Thus, we believe the algorithm followed in the present study is more aligned with the typical clinical
practice approaches used by most physicians who treat
patients with NTOS.
The physical therapy regimen used throughout the present study was speciﬁc to NTOS, differing from the physical therapy approaches typical for other neck and upper
extremity conditions.23-27 This is important to ensure an
adequate trial of conservative management before
considering surgery. We also found that the initial physical therapy trial was valuable even for patients considered likely to require surgical treatment, because the
physical therapy trial allowed the therapist to establish
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Fig 5. Forest plot for multivariate logistic regression of pretreatment patient-reported outcomes measures
(PROMs) to predict response to surgical treatment for neurogenic thoracic outlet syndrome (NTOS). Data shown
indicate odds ratios (ORs) and 95% conﬁdence intervals (CIs; in parentheses) for each PROM and corrected for
age, gender, and symptom duration >2 years. BPI, Brief Pain Inventory; CBSQ, Cervical-Brachial Symptom
Questionnaire; PCS, Pain Catastrophizing Scale; SDS, Self-rating Depression Scale; SF-12, Short Form, 12-item
quality of life questionnaire.

a baseline status for the individual patient, teach NTOSspeciﬁc protocols, help manage expectations for treatment, and better anticipate speciﬁc needs that might
arise during postoperative rehabilitation. An integrated
multidisciplinary center has an advantage compared
with practice settings in which NTOS is treated only on
an occasional basis without established protocols.
It is notable that our initial assessment approach did
not include the routine use of anterior scalene and pectoralis minor muscle blocks nor were positive ﬁndings
from muscle blocks considered necessary before
patients could be considered for surgery. Although
Lum et al,33 Jordan and Machleder,34 and Jordan35
described better outcomes from surgical treatment for
patients with positive ﬁndings from pretreatment muscle blocks, we found in our cohort that muscle blocks
did not serve as a statistically signiﬁcant predictor of
the surgical treatment outcome. The present cohort
was relatively small for rigorous analysis of this question
and we found found a strong trend toward improved
outcomes in patients with positive ﬁndings from a muscle block. Thus, we cannot conclude that the ﬁndings
from muscle blocks have no predictive value and believe
this question warrants ongoing study.
The assessment of patient disability using well-deﬁned
PROMs represents a quantiﬁable approach to evaluate
the effectiveness of a treatment. In the present study,
the most useful PROMs for the evaluation of patients
with NTOS appeared to be the QuickDASH, CBSQ,
and SF-12 physical QOL. The use of changes in the
QuickDASH score to assess treatment outcomes has a
distinct advantage, providing an objective measure of

the disability with an instrument widely used for
patients with NTOS and other upper extremity
conditions.7,10-13,15,16,19,36,37 In contrast, PROMs related to
the domain of pain appeared redundant and not as useful in assessing disability, overall functional limitations,
and QOL. Although in our previous study, high pain catastrophizing was evident in 38% of patients with NTOS,
the pretreatment PCS scores did not predict the outcomes after surgical treatment. This suggests that pain
catastrophizing is more variable than previously considered and might respond favorably to improvements in
physical symptoms. Our data showed that follow-up
PCS scores decreased signiﬁcantly in those with favorable patient-rated outcomes.38,39 It remains unclear
whether this was simply a consequence of symptom
improvement; however, persistently high pain catastrophizing might help identify patients at risk of poor
outcomes. On multivariate analysis of other predictors
of outcome, we found that only the SF-12 physical QOL
score was signiﬁcantly associated with the response to
surgical treatment. The odds ratio for this association
was nonetheless relatively small, indicating that the
results predicted from this single instrument should
not be considered strong enough to guide treatment
decisions.
The present study had several limitations. First, as noted in
our initial study, the patients in our cohort likely exhibited a
greater degree of disability at initial presentation than
might be seen in other practice settings, and patients
with milder degrees of NTOS might have a greater likelihood of satisfactory improvement with physical therapy
alone.7 Our outcomes thereby reﬂect a dedicated
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multidisciplinary referral program for the management of
NTOS and might not translate to practices with less experience with physical therapy or surgical treatment.
One difﬁculty with the QuickDASH instrument has
been that for patients with bilateral symptoms, the functional improvement after treatment for 1 limb might be
overshadowed by persistent limitations in the contralateral (untreated) limb. The QuickDASH scores can also
vary inconsistently at different follow-up intervals after
treatment. In the present study, we chose to use the
QuickDASH score measured at the longest follow-up interval rather than at a single ﬁxed follow-up interval;
however, neither approach can capture any ﬂuctuations
in disability over time or with different patient trajectories. We also did not investigate late secondary injury
or long-term recurrence of NTOS, but these will be the
subject of future investigation. Because of the recognized potential for late recurrence after surgical treatment for NTOS, follow-up examinations for $2 years
postoperatively have been suggested for analysis of late
outcomes.2,40
Finally, the present study represents just 1 cohort of
patients accrued during a 6-month period. The results
might, therefore, differ somewhat with a larger cohort.
It would be valuable to have a larger database of patients
with NTOS available, such as a national registry, for larger
scale studies in the future.2,41,42

CONCLUSIONS
The results of the present study have demonstrated
contemporary outcomes for physical therapy and surgical treatment in a well-studied cohort of patients with
NTOS, reinforcing that surgery can be effective when
physical therapy is insufﬁcient, even with substantial
pretreatment disability. Substantial improvement in
symptoms can be expected for w90% of patients after
surgical treatment for NTOS and is reﬂected by
changes in the QuickDASH scores. Patients undergoing
surgical treatment experienced a greater extent of
improvement compared with those undergoing physical therapy alone. However, in our cohort, it was difﬁcult to identify speciﬁc predictive factors for
individuals most likely to beneﬁt from physical therapy
or from surgical treatment.
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